Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 4 Prostatic Neoplasms 2 Neoplastic Syndromes, Hereditary 2 Colorectal Neoplasms, Hereditary Nonpolyposis 2 Colorectal Neoplasms 2 Carcinoma, Intraductal, Noninfiltrating 2 Tuberous Sclerosis 1 Thyroid Neoplasms 1 Sarcoma 1 Pyloric Stenosis, Hypertrophic 1 Pheochromocytoma 1 Paraganglioma 1 Pancreatic Ductal Adenocarcinoma 1 Ovarian Neoplasms 1 Neoplasms, Unknown Primary 1 Neoplasms 1 Multiple Myeloma 1 Melanoma 1 Lymphoproliferative Disorders 1 Lymphangioleiomyomatosis 1 Kidney Neoplasms 1 Hormone Receptor Positive Breast Cancer 1 Hereditary Breast and Ovarian Cancer Syndrome 1 Hematopoietic and Lymphatic System Neoplasm 1 Hematologic Neoplasms 1 HER2-positive Breast Cancer 1 Glioma 1 Early Detection of Cancer 1 Breast Carcinoma In Situ 1 Brain Neoplasms 1

Interventions

Tablets 1 Genetic Testing 1 Everolimus 1 Blood Specimen Collection 1 Biomarkers 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Hormone Receptor Positive Breast Cancer × Genetic Testing × Clear all

NCT07646171 2026-06-12

MBC

Tel-Aviv Sourasky Medical Center

Hormone Receptor Positive Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡